Front Endocrinol (Lausanne) 14(12):735824 Cheng L, Hu Y, Li YY, Cao X, Bai N, Lu TT, Li GQ, Li N, Wang AN, Mao XM (2019) Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
Dual Board Certified 25+ Yrs Experience Clinical Faculty Elaine Briggs, DNP, FNP-C Nurse Practitioner Primary Care & Telehealth Your go-to for visits, refills, and questions by phone or video
People who have side effects like nausea when they begin to increase their dose typically stay at the largest dose they can tolerate instead of escalating until hitting the maximum dose as the FDA recommends
When you hit a plateau or weight loss significantly slows down, you move up to the next level and continue your weight loss journey